PROLACTINOMA
Clinical trials for PROLACTINOMA explained in plain language.
Never miss a new study
Get alerted when new PROLACTINOMA trials appear
Sign up with your email to follow new studies for PROLACTINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Short, strong dose tested to shrink common brain tumors
Disease control Recruiting nowThis study is testing if a short, high-dose treatment with the drug cabergoline can put small, benign pituitary tumors (prolactinomas) into remission. It compares this 6-month high-dose approach to the standard treatment, which uses the lowest effective dose for two years. The go…
Matched conditions: PROLACTINOMA
Phase: PHASE3 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Common brain tumor drug put to the test: does it worsen diabetes risk?
Disease control Recruiting nowThis study aims to see if different treatment approaches with the standard drug cabergoline affect blood sugar and insulin levels in people with prolactinoma, a common benign pituitary tumor. It will enroll 60 adults who are either newly diagnosed or already on stable treatment. …
Matched conditions: PROLACTINOMA
Phase: PHASE4 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Scientists hunt for genetic clues to childhood brain tumors
Knowledge-focused Recruiting nowThis study aims to understand the genetic causes and family patterns of pituitary and brain tumors, which are common in children. Researchers will collect blood and tissue samples from up to 2,000 participants, including patients and their family members, to study the genes invol…
Matched conditions: PROLACTINOMA
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Apr 04, 2026 01:50 UTC
-
Could estrogen levels explain why some pituitary tumors grow larger?
Knowledge-focused Recruiting nowThis study aims to understand if a woman's lifetime exposure to estrogen influences whether she develops a larger or smaller type of prolactinoma, a common pituitary tumor. Researchers will compare the medical and reproductive histories of 180 women who have already been diagnose…
Matched conditions: PROLACTINOMA
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC